Impact of regional left ventricular function on outcome for patients with AL amyloidosis.

<h4>Objectives</h4>The aim of this study was to explore the left ventricular (LV) deformation changes and the potential impact of deformation on outcome in patients with proven light-chain (AL) amyloidosis and LV hypertrophy.<h4>Background</h4>Cardiac involvement in AL amyloi...

Full description

Bibliographic Details
Main Authors: Dan Liu, Kai Hu, Markus Niemann, Sebastian Herrmann, Maja Cikes, Stefan Störk, Meinrad Beer, Philipp Daniel Gaudron, Caroline Morbach, Stefan Knop, Eva Geissinger, Georg Ertl, Bart Bijnens, Frank Weidemann
Format: Article
Language:English
Published: Public Library of Science (PLoS) 2013-01-01
Series:PLoS ONE
Online Access:https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/23520459/?tool=EBI
_version_ 1818723858396479488
author Dan Liu
Kai Hu
Markus Niemann
Sebastian Herrmann
Maja Cikes
Stefan Störk
Meinrad Beer
Philipp Daniel Gaudron
Caroline Morbach
Stefan Knop
Eva Geissinger
Georg Ertl
Bart Bijnens
Frank Weidemann
author_facet Dan Liu
Kai Hu
Markus Niemann
Sebastian Herrmann
Maja Cikes
Stefan Störk
Meinrad Beer
Philipp Daniel Gaudron
Caroline Morbach
Stefan Knop
Eva Geissinger
Georg Ertl
Bart Bijnens
Frank Weidemann
author_sort Dan Liu
collection DOAJ
description <h4>Objectives</h4>The aim of this study was to explore the left ventricular (LV) deformation changes and the potential impact of deformation on outcome in patients with proven light-chain (AL) amyloidosis and LV hypertrophy.<h4>Background</h4>Cardiac involvement in AL amyloidosis patients is associated with poor outcome. Detecting regional cardiac function by advanced non-invasive techniques might be favorable for predicting outcome.<h4>Methods</h4>LV longitudinal, circumferential and radial peak systolic strains (Ssys) were assessed by speckle tracking imaging (STI) in 44 biopsy-proven systemic AL amyloidosis patients with LV hypertrophy (CA) and in 30 normal controls. Patients were divided into compensated (n = 18) and decompensated (n = 26) group based on clinical assessment and followed-up for a median period of 345 days.<h4>Results</h4>Ejection fraction (EF) was preserved while longitudinal Ssys (LSsys) was significantly reduced in both compensated and decompensated groups. Survival was significantly reduced in decompensated group (35% vs. compensated 78%, P = 0.001). LSsys were similar in apical segments and significantly reduced in basal segments between two patient groups. LSsys at mid-segments were significantly reduced in all LV walls of decompensated group. Patients were further divided into 4 subgroups according to the presence or absence of reduced LSsys in no (normal), only basal (mild), basal and mid (intermediate) and all segments of the septum (severe). This staging revealed continuously worse prognosis in proportion to increasing number of segments with reduced LSsys (mortality: normal 14%, mild 27%, intermediate 67%, and severe 64%). Mid-septum LSsys<11% suggested a 4.8-fold mortality risk than mid-septum LSsys≥11%. Multivariate regression analysis showed NYHA class and mid-septum LSsys were independent predictors for survival.<h4>Conclusions</h4>Reduced deformation at mid-septum is associated with worse prognosis in systemic amyloidosis patients with LV hypertrophy.
first_indexed 2024-12-17T21:17:12Z
format Article
id doaj.art-383aaf2963ed48998f200e7d8c39eabd
institution Directory Open Access Journal
issn 1932-6203
language English
last_indexed 2024-12-17T21:17:12Z
publishDate 2013-01-01
publisher Public Library of Science (PLoS)
record_format Article
series PLoS ONE
spelling doaj.art-383aaf2963ed48998f200e7d8c39eabd2022-12-21T21:32:19ZengPublic Library of Science (PLoS)PLoS ONE1932-62032013-01-0183e5692310.1371/journal.pone.0056923Impact of regional left ventricular function on outcome for patients with AL amyloidosis.Dan LiuKai HuMarkus NiemannSebastian HerrmannMaja CikesStefan StörkMeinrad BeerPhilipp Daniel GaudronCaroline MorbachStefan KnopEva GeissingerGeorg ErtlBart BijnensFrank Weidemann<h4>Objectives</h4>The aim of this study was to explore the left ventricular (LV) deformation changes and the potential impact of deformation on outcome in patients with proven light-chain (AL) amyloidosis and LV hypertrophy.<h4>Background</h4>Cardiac involvement in AL amyloidosis patients is associated with poor outcome. Detecting regional cardiac function by advanced non-invasive techniques might be favorable for predicting outcome.<h4>Methods</h4>LV longitudinal, circumferential and radial peak systolic strains (Ssys) were assessed by speckle tracking imaging (STI) in 44 biopsy-proven systemic AL amyloidosis patients with LV hypertrophy (CA) and in 30 normal controls. Patients were divided into compensated (n = 18) and decompensated (n = 26) group based on clinical assessment and followed-up for a median period of 345 days.<h4>Results</h4>Ejection fraction (EF) was preserved while longitudinal Ssys (LSsys) was significantly reduced in both compensated and decompensated groups. Survival was significantly reduced in decompensated group (35% vs. compensated 78%, P = 0.001). LSsys were similar in apical segments and significantly reduced in basal segments between two patient groups. LSsys at mid-segments were significantly reduced in all LV walls of decompensated group. Patients were further divided into 4 subgroups according to the presence or absence of reduced LSsys in no (normal), only basal (mild), basal and mid (intermediate) and all segments of the septum (severe). This staging revealed continuously worse prognosis in proportion to increasing number of segments with reduced LSsys (mortality: normal 14%, mild 27%, intermediate 67%, and severe 64%). Mid-septum LSsys<11% suggested a 4.8-fold mortality risk than mid-septum LSsys≥11%. Multivariate regression analysis showed NYHA class and mid-septum LSsys were independent predictors for survival.<h4>Conclusions</h4>Reduced deformation at mid-septum is associated with worse prognosis in systemic amyloidosis patients with LV hypertrophy.https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/23520459/?tool=EBI
spellingShingle Dan Liu
Kai Hu
Markus Niemann
Sebastian Herrmann
Maja Cikes
Stefan Störk
Meinrad Beer
Philipp Daniel Gaudron
Caroline Morbach
Stefan Knop
Eva Geissinger
Georg Ertl
Bart Bijnens
Frank Weidemann
Impact of regional left ventricular function on outcome for patients with AL amyloidosis.
PLoS ONE
title Impact of regional left ventricular function on outcome for patients with AL amyloidosis.
title_full Impact of regional left ventricular function on outcome for patients with AL amyloidosis.
title_fullStr Impact of regional left ventricular function on outcome for patients with AL amyloidosis.
title_full_unstemmed Impact of regional left ventricular function on outcome for patients with AL amyloidosis.
title_short Impact of regional left ventricular function on outcome for patients with AL amyloidosis.
title_sort impact of regional left ventricular function on outcome for patients with al amyloidosis
url https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/23520459/?tool=EBI
work_keys_str_mv AT danliu impactofregionalleftventricularfunctiononoutcomeforpatientswithalamyloidosis
AT kaihu impactofregionalleftventricularfunctiononoutcomeforpatientswithalamyloidosis
AT markusniemann impactofregionalleftventricularfunctiononoutcomeforpatientswithalamyloidosis
AT sebastianherrmann impactofregionalleftventricularfunctiononoutcomeforpatientswithalamyloidosis
AT majacikes impactofregionalleftventricularfunctiononoutcomeforpatientswithalamyloidosis
AT stefanstork impactofregionalleftventricularfunctiononoutcomeforpatientswithalamyloidosis
AT meinradbeer impactofregionalleftventricularfunctiononoutcomeforpatientswithalamyloidosis
AT philippdanielgaudron impactofregionalleftventricularfunctiononoutcomeforpatientswithalamyloidosis
AT carolinemorbach impactofregionalleftventricularfunctiononoutcomeforpatientswithalamyloidosis
AT stefanknop impactofregionalleftventricularfunctiononoutcomeforpatientswithalamyloidosis
AT evageissinger impactofregionalleftventricularfunctiononoutcomeforpatientswithalamyloidosis
AT georgertl impactofregionalleftventricularfunctiononoutcomeforpatientswithalamyloidosis
AT bartbijnens impactofregionalleftventricularfunctiononoutcomeforpatientswithalamyloidosis
AT frankweidemann impactofregionalleftventricularfunctiononoutcomeforpatientswithalamyloidosis